Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Functional Analysis Reveals Geographical Variation in Inhibitory Immune Responses Against a Polymorphic Malaria Antigen.

Bei AK, Ahouidi AD, Dvorin JD, Miura K, Diouf A, Ndiaye D, Premji Z, Diakite M, Mboup S, Long CA, Duraisingh MT.

J Infect Dis. 2017 Jul 15;216(2):267-275. doi: 10.1093/infdis/jix280.

2.

Anti-Plasmodium falciparum invasion ligand antibodies in a low malaria transmission region, Loreto, Peru.

Villasis E, Lopez-Perez M, Torres K, Gamboa D, Neyra V, Bendezu J, Tricoche N, Lobo C, Vinetz JM, Lustigman S.

Malar J. 2012 Oct 30;11:361. doi: 10.1186/1475-2875-11-361.

3.

Defining the antigenic diversity of Plasmodium falciparum apical membrane antigen 1 and the requirements for a multi-allele vaccine against malaria.

Drew DR, Hodder AN, Wilson DW, Foley M, Mueller I, Siba PM, Dent AE, Cowman AF, Beeson JG.

PLoS One. 2012;7(12):e51023. doi: 10.1371/journal.pone.0051023. Epub 2012 Dec 5.

4.

Inhibitory humoral responses to the Plasmodium falciparum vaccine candidate EBA-175 are independent of the erythrocyte invasion pathway.

Badiane AS, Bei AK, Ahouidi AD, Patel SD, Salinas N, Ndiaye D, Sarr O, Ndir O, Tolia NH, Mboup S, Duraisingh MT.

Clin Vaccine Immunol. 2013 Aug;20(8):1238-45. doi: 10.1128/CVI.00135-13. Epub 2013 Jun 12.

5.

Population genetic analysis of large sequence polymorphisms in Plasmodium falciparum blood-stage antigens.

Ahouidi AD, Bei AK, Neafsey DE, Sarr O, Volkman S, Milner D, Cox-Singh J, Ferreira MU, Ndir O, Premji Z, Mboup S, Duraisingh MT.

Infect Genet Evol. 2010 Mar;10(2):200-6. doi: 10.1016/j.meegid.2009.11.008. Epub 2009 Nov 30.

6.

Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate.

Ntege EH, Arisue N, Ito D, Hasegawa T, Palacpac NMQ, Egwang TG, Horii T, Takashima E, Tsuboi T.

Vaccine. 2016 Nov 4;34(46):5612-5622. doi: 10.1016/j.vaccine.2016.09.028. Epub 2016 Sep 28.

PMID:
27692771
7.

Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.

Lalitha PV, Biswas S, Pillai CR, Saxena RK.

Vaccine. 2008 Aug 18;26(35):4526-35. doi: 10.1016/j.vaccine.2008.06.031. Epub 2008 Jun 30.

PMID:
18590786
8.

Vaccination with conserved regions of erythrocyte-binding antigens induces neutralizing antibodies against multiple strains of Plasmodium falciparum.

Healer J, Thompson JK, Riglar DT, Wilson DW, Chiu YH, Miura K, Chen L, Hodder AN, Long CA, Hansen DS, Baum J, Cowman AF.

PLoS One. 2013 Sep 10;8(9):e72504. doi: 10.1371/journal.pone.0072504. eCollection 2013.

9.

The Plasmodium falciparum erythrocyte invasion ligand Pfrh4 as a target of functional and protective human antibodies against malaria.

Reiling L, Richards JS, Fowkes FJ, Wilson DW, Chokejindachai W, Barry AE, Tham WH, Stubbs J, Langer C, Donelson J, Michon P, Tavul L, Crabb BS, Siba PM, Cowman AF, Mueller I, Beeson JG.

PLoS One. 2012;7(9):e45253. doi: 10.1371/journal.pone.0045253. Epub 2012 Sep 20.

10.

Antibodies to polymorphic invasion-inhibitory and non-Inhibitory epitopes of Plasmodium falciparum apical membrane antigen 1 in human malaria.

Mugyenyi CK, Elliott SR, McCallum FJ, Anders RF, Marsh K, Beeson JG.

PLoS One. 2013 Jul 5;8(7):e68304. doi: 10.1371/journal.pone.0068304. Print 2013.

11.

The stage-specific in vitro efficacy of a malaria antigen cocktail provides valuable insights into the development of effective multi-stage vaccines.

Spiegel H, Boes A, Kastilan R, Kapelski S, Edgue G, Beiss V, Chubodova I, Scheuermayer M, Pradel G, Schillberg S, Reimann A, Fischer R.

Biotechnol J. 2015 Oct;10(10):1651-9. doi: 10.1002/biot.201500055. Epub 2015 May 26.

PMID:
25913888
12.

Identification of a potent combination of key Plasmodium falciparum merozoite antigens that elicit strain-transcending parasite-neutralizing antibodies.

Pandey AK, Reddy KS, Sahar T, Gupta S, Singh H, Reddy EJ, Asad M, Siddiqui FA, Gupta P, Singh B, More KR, Mohmmed A, Chitnis CE, Chauhan VS, Gaur D.

Infect Immun. 2013 Feb;81(2):441-51. doi: 10.1128/IAI.01107-12. Epub 2012 Nov 26.

13.

Immunogenicity of single versus mixed allele vaccines of Plasmodium vivax Duffy binding protein region II.

Ntumngia FB, Schloegel J, McHenry AM, Barnes SJ, George MT, Kennedy S, Adams JH.

Vaccine. 2013 Sep 13;31(40):4382-8. doi: 10.1016/j.vaccine.2013.07.002. Epub 2013 Jul 31.

14.

Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.

Perraut R, Varela ML, Joos C, Diouf B, Sokhna C, Mbengue B, Tall A, Loucoubar C, Touré A, Mercereau-Puijalon O.

Vaccine. 2017 Dec 4;35(48 Pt B):6720-6726. doi: 10.1016/j.vaccine.2017.10.012. Epub 2017 Oct 15.

PMID:
29042203
15.

RALP1 is a rhoptry neck erythrocyte-binding protein of Plasmodium falciparum merozoites and a potential blood-stage vaccine candidate antigen.

Ito D, Hasegawa T, Miura K, Yamasaki T, Arumugam TU, Thongkukiatkul A, Takeo S, Takashima E, Sattabongkot J, Han ET, Long CA, Torii M, Tsuboi T.

Infect Immun. 2013 Nov;81(11):4290-8. doi: 10.1128/IAI.00690-13. Epub 2013 Sep 3.

16.
17.

Allele specificity of naturally acquired antibody responses against Plasmodium falciparum apical membrane antigen 1.

Cortés A, Mellombo M, Masciantonio R, Murphy VJ, Reeder JC, Anders RF.

Infect Immun. 2005 Jan;73(1):422-30.

18.

Bacterially expressed full-length recombinant Plasmodium falciparum RH5 protein binds erythrocytes and elicits potent strain-transcending parasite-neutralizing antibodies.

Reddy KS, Pandey AK, Singh H, Sahar T, Emmanuel A, Chitnis CE, Chauhan VS, Gaur D.

Infect Immun. 2014 Jan;82(1):152-64. doi: 10.1128/IAI.00970-13. Epub 2013 Oct 14.

19.

Allelic polymorphisms in apical membrane antigen-1 are responsible for evasion of antibody-mediated inhibition in Plasmodium falciparum.

Healer J, Murphy V, Hodder AN, Masciantonio R, Gemmill AW, Anders RF, Cowman AF, Batchelor A.

Mol Microbiol. 2004 Apr;52(1):159-68.

20.

Acquisition of antibodies to merozoite surface protein 3 among residents of Korogwe, north eastern Tanzania.

Segeja MD, Mmbando BP, Seth MD, Lusingu JP, Lemnge MM.

BMC Infect Dis. 2010 Mar 8;10:55. doi: 10.1186/1471-2334-10-55.

Supplemental Content

Support Center